-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Haemonetics Corp quarterly/annual Depreciation history and growth rate from Q2 2022 to Q2 2024.
- Haemonetics Corp Depreciation for the quarter ending June 29, 2024 was $14.6M, a 9.77% increase year-over-year.
- Haemonetics Corp Depreciation for the twelve months ending June 29, 2024 was $57.1M, a 8.14% increase year-over-year.
- Haemonetics Corp annual Depreciation for 2023 was $55.8M, a 8.98% increase from 2022.
- Haemonetics Corp annual Depreciation for 2022 was $51.2M, a 15.3% increase from 2021.
- Haemonetics Corp annual Depreciation for 2021 was $44.4M, a 3.02% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)